Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy

• Published in: Cell death discovery 2023-07, Vol.9 (1), p.243-243, Article 243
• Main Authors: Daley, Rachel, Maddipatla, Vishnu, Ghosh, Sayan, Chowdhury, Olivia, Hose, Stacey, Zigler, J. Samuel, Sinha, Debasish, Liu, Haitao
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; 631/61; 631/80; AKT2 protein; Apoptosis; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Cycle Analysis; Collagen (type IV); Connective tissue growth factor; Connective tissues; Diabetes; Diabetes mellitus; Diabetic retinopathy; E-cadherin; Explants; Fibronectin; Fibrosis; Life Sciences; Retina; Retinopathy; Stem Cells; Streptozocin; Vascular endothelial growth factor; Zonula occludens-1 protein
• ISSN: 2058-7716; 2058-7716
• DOI: 10.1038/s41420-023-01545-4

Diabetic Retinopathy (DR) is a complication of diabetes that causes blindness in adults. Retinal fibrosis is closely associated with developing proliferative diabetic retinopathy (PDR). Clinical studies have shown that fibrotic membranes exhibit uncontrolled growth in PDR and contribute to retinal detachment from RPE cells, ultimately leading to vision loss. While anti-VEGF agents and invasive laser treatments are the primary treatments for PDR, retinal fibrosis has received minimal attention as a potential target for therapeutic intervention. Therefore, to investigate the potential role of Akt2 in the diabetes-induced retinal fibrosis process, we generated RPE-specific Akt2 conditional knockout (cKO) mice and induced diabetes in these mice and Akt2 fl/fl control mice by intraperitoneal injection of streptozotocin. After an 8-month duration of diabetes (10 months of age), the mice were euthanized and expression of tight junction proteins, epithelial–mesenchymal transition (EMT), and fibrosis markers were examined in the RPE. Diabetes induction in the floxed control mice decreased levels of the RPE tight junction protein ZO-1 and adherens junction proteins occludin and E-cadherin; these decreases were rescued in Akt2 cKO diabetic mice. Loss of Akt2 also inhibited diabetes-induced elevation of RNA and protein levels of the EMT markers Snail/Slug and Twist1 in the RPE as compared to Akt2 fl/fl diabetic mice. We also found that in Akt2 cKO mice diabetes-induced increase of fibrosis markers, including collagen IV, Connective tissue growth factor (CTGF), fibronectin, and alpha-SMA was attenuated. Furthermore, we observed that high glucose-induced alterations in EMT and fibrosis markers in wild-type (WT) RPE explants were rescued in the presence of PI3K and ERK inhibitors, indicating diabetes-induced retinal fibrosis may be mediated via the PI3K/Akt2/ERK signaling, which could provide a novel target for DR therapy.